# Research Proposal: Goal-Conditioned Reinforcement Learning for Compositional Multi-Property Molecular Design

## 1. Title

**Goal-Conditioned Reinforcement Learning with Contrastive Encoding and Hindsight Experience Replay for Zero-Shot Compositional Molecular Design**

## 2. Introduction

### 2.1 Background

Molecular design for drug discovery represents one of the most challenging optimization problems in computational chemistry. Traditional approaches require chemists to manually navigate vast chemical spaces (estimated at $10^{60}$ drug-like molecules) to identify candidates satisfying multiple competing property constraints: binding affinity to target proteins, drug-likeness (QED), synthetic accessibility (SA score), lipophilicity (logP), and toxicity. Current computational methods employ multi-objective reinforcement learning (RL) to automate this search, but face critical limitations: (1) fixed reward functions require complete retraining when property requirements change, (2) multi-property success rates plateau at 50-60% due to conflicting objectives, and (3) exponential scaling of training cost with the number of properties ($2^k$ combinations for $k$ properties).

Recent advances in goal-conditioned reinforcement learning (GCRL) offer a promising alternative paradigm. Unlike traditional RL where reward functions are fixed at training time, GCRL enables dynamic goal specification at inference time—users provide desired outcomes as observations rather than mathematical reward functions. Theoretical work by Eysenbach et al. (2022) established that contrastive learning objectives align with goal-conditioned value functions, providing a principled framework for learning goal representations where inner products correspond to value differences. Complementary work by Haramati et al. (2024) demonstrated compositional generalization in entity-centric RL, where training on 3 objects enabled zero-shot transfer to 10+ objects in robotic manipulation tasks.

These developments suggest a transformative opportunity: Can GCRL enable compositional molecular generation where training on simple property combinations (e.g., 2-property goals) generalizes zero-shot to complex multi-property specifications (3+ properties) while improving success rates beyond current 50-60% baselines?

### 2.2 Research Objectives

This research addresses three primary objectives:

**Objective 1: Develop a goal-conditioned RL framework for molecular design** that enables dynamic multi-property specification at inference time, eliminating the need for retraining when property requirements change.

**Objective 2: Achieve compositional generalization** where training on $k$-property goal combinations enables zero-shot transfer to $(k+1)$-property goals through contrastive goal encoding and hindsight experience replay (HER).

**Objective 3: Improve multi-property success rates** from current 50-60% baselines to >75% by leveraging flexible goal-conditioning and uncertainty-aware property prediction.

### 2.3 Research Hypothesis

**Main Hypothesis:** In molecular design tasks with multiple property constraints, if we train a goal-conditioned policy with Junction Tree VAE (JT-VAE) latent space navigation and uncertainty-aware property predictors using hindsight experience replay with property relabeling, then the system will generate molecules matching specified multi-property goals with zero-shot generalization to novel property combinations because the contrastive goal encoder learns a compositional property space where inner products correspond to goal-conditioned value functions.

**Mechanistic Rationale:** The hypothesis operates through a five-step causal chain:

1. **Contrastive goal encoding** maps property goal vectors $g \in \mathbb{R}^5$ to latent representations $z_g \in \mathbb{R}^{64}$ where $z_g \cdot z_{g'} = V(s,g) - V(s,g')$ (Eysenbach 2022)
2. **Goal-conditioned policy** $\pi(a|s,z_g)$ navigates JT-VAE latent space conditioned on goal embeddings
3. **JT-VAE decoder** ensures 100% chemical validity through tree-structured molecular generation (Jin et al. 2018)
4. **Uncertainty-aware ensemble predictors** prevent exploitation via reward shaping: $r = \sum_i \text{match}(p_i, g_i) - \lambda \sigma_p$ (Chen et al. 2025)
5. **HER property relabeling** creates compositional learning signals by relabeling failed trajectories with achieved properties, enabling zero-shot generalization (Andrychowicz et al. 2017; Haramati et al. 2024)

### 2.4 Significance

This research offers transformative contributions across theoretical, methodological, and practical dimensions:

**Theoretical Significance:**
- First formalization of molecular design as goal-conditioned RL with continuous property spaces
- Extension of compositional generalization theory from discrete robotic objects (Haramati 2024) to continuous molecular properties
- Theoretical analysis of HER dynamics in continuous property relabeling

**Methodological Significance:**
- Novel integration of contrastive learning, JT-VAE latent space navigation, and uncertainty-aware HER for molecular GCRL
- Solution to discrete molecular action space challenge while maintaining chemical validity guarantees
- Uncertainty quantification framework preventing property predictor exploitation

**Practical Significance:**
- **Customizable drug design:** Chemists specify desired properties dynamically (e.g., "binding affinity 0.8, QED 0.7, SA 0.6") without retraining
- **Data efficiency:** HER augmentation reduces training data requirements by 30-50% (estimated from robotics HER results)
- **Scalability:** Zero-shot composition eliminates exponential training cost scaling with property count
- **Interpretability:** Goal interpolation enables systematic exploration of property trade-off frontiers

The work directly addresses workshop themes: (1) **Connections** between GCRL and representation learning through contrastive encoding, (2) **Algorithms** via novel HER adaptation to molecular domains, and (3) **Applications** extending GCRL to molecular discovery where it is not yet mainstream.

## 3. Methodology

### 3.1 Overall Framework Architecture

The proposed system consists of five integrated components operating in a closed loop:

**Component 1: Contrastive Goal Encoder** $\phi: \mathbb{R}^5 \rightarrow \mathbb{R}^{64}$  
**Component 2: Goal-Conditioned Actor-Critic** $\pi(a|s,z_g)$, $Q(s,a,z_g)$  
**Component 3: JT-VAE Molecular Decoder** $D: \mathbb{R}^{56} \rightarrow \text{SMILES}$  
**Component 4: Uncertainty-Aware Property Ensemble** $\{P_1, ..., P_5\}$  
**Component 5: HER Property Relabeling Buffer** $\mathcal{B}_{\text{HER}}$

### 3.2 Data Collection and Preprocessing

**Training Dataset:**
- **Source:** ChEMBL database (1M drug-like molecules) or ZINC250k
- **Preprocessing:** 
  - Filter molecules: 150-500 Da molecular weight, ≤40 heavy atoms, valid SMILES
  - Compute properties: QED (RDKit), SA score (SAScore), logP (RDKit descriptors)
  - Docking simulation: AutoDock Vina for binding affinity to 10 common drug targets
  - Toxicity prediction: Pre-trained GNN ensemble on Tox21 dataset
- **Stratified splitting:** 70% train / 15% validation / 15% test, stratified by property quintiles to ensure representative distributions

**Property Normalization:**
All properties normalized to $[0,1]$ range:
$$p_{\text{norm}} = \frac{p - p_{\min}}{p_{\max} - p_{\min}}$$

where ranges are: QED $[0,1]$, SA $[1,10]$, Binding $[-12, 0]$ kcal/mol, logP $[-2, 6]$, Toxicity $[0,1]$.

**Goal Sampling Strategy:**
- **Training:** Sample 2-property goals uniformly from property pairs: {(binding, QED), (QED, SA), (SA, logP), (logP, toxicity)}
- **Validation:** Sample 2-property and 3-property goals
- **Test:** 1000 held-out goals (500 two-property + 500 three-property combinations)

### 3.3 Component 1: Contrastive Goal Encoder

**Architecture:**
3-layer MLP: $\mathbb{R}^5 \xrightarrow{\text{Linear}(128)} \text{ReLU} \xrightarrow{\text{Linear}(128)} \text{ReLU} \xrightarrow{\text{Linear}(64)} \mathbb{R}^{64}$

**Training Objective (Eysenbach 2022):**
$$\mathcal{L}_{\text{contrastive}} = -\mathbb{E}_{(s,a,s',g)} \left[ \log \frac{\exp(\phi(g)^\top \psi(s,a,s'))}{\sum_{g' \in \mathcal{G}} \exp(\phi(g')^\top \psi(s,a,s'))} \right]$$

where:
- $\phi(g)$: goal encoder
- $\psi(s,a,s')$: transition encoder (3-layer MLP: $\mathbb{R}^{56+56+56} \rightarrow \mathbb{R}^{64}$)
- $\mathcal{G}$: batch of negative goal samples (size 256)

**Theoretical Guarantee (Eysenbach 2022):**
Under optimal encoder, $\phi(g)^\top \phi(g') \propto V^*(s,g) - V^*(s,g')$, enabling compositional value estimation.

**Implementation Details:**
- Optimizer: Adam with learning rate $3 \times 10^{-4}$
- Batch size: 256 transitions
- Negative samples: 256 random goals per batch
- Training: 100K gradient steps on pre-collected molecular trajectories

### 3.4 Component 2: Goal-Conditioned Actor-Critic

**State Space:** JT-VAE latent vectors $s \in \mathbb{R}^{56}$  
**Action Space:** Continuous latent space perturbations $a \in \mathbb{R}^{56}$, $||a|| \leq 0.5$  
**Goal Space:** Encoded goal embeddings $z_g = \phi(g) \in \mathbb{R}^{64}$

**Actor Network:**
$$\pi_\theta(a|s,z_g): \mathbb{R}^{56+64} \xrightarrow{\text{MLP}(256,256,256)} \mathcal{N}(\mu_a, \sigma_a)$$

Outputs Gaussian distribution over actions with mean $\mu_a$ and diagonal covariance $\sigma_a$.

**Critic Network:**
$$Q_\omega(s,a,z_g): \mathbb{R}^{56+56+64} \xrightarrow{\text{MLP}(256,256,256)} \mathbb{R}$$

**Training Algorithm (TD3 with Goal Conditioning):**

```
Initialize actor π_θ, critic Q_ω, target networks π_θ', Q_ω'
Initialize contrastive encoder φ (pre-trained)
Initialize replay buffer B_HER
Initialize JT-VAE decoder D (pre-trained on ChEMBL)
Initialize property ensemble {P_1, ..., P_5}

for episode = 1 to N_episodes:
    Sample goal g ~ Uniform([0,1]^5)
    Encode goal: z_g = φ(g)
    Sample initial molecule m_0 ~ ChEMBL
    Encode to latent: s_0 = Encoder_VAE(m_0)
    
    for t = 0 to T_max:
        # Action selection
        a_t ~ π_θ(·|s_t, z_g) + ε, ε ~ N(0, σ_explore)
        
        # State transition in latent space
        s_{t+1} = s_t + a_t
        s_{t+1} = clip(s_{t+1}, latent_bounds)
        
        # Decode to molecule
        m_{t+1} = D(s_{t+1})
        
        # Property evaluation with uncertainty
        p(m_{t+1}) = [P_1(m), ..., P_5(m)]  # Ensemble mean
        σ_p = std([P_1(m), ..., P_5(m)])    # Ensemble disagreement
        
        # Reward computation
        r_t = -||p(m_{t+1}) - g||_2 - λ·σ_p
        
        # Store transition
        B_HER.store((s_t, a_t, r_t, s_{t+1}, g))
        
        if r_t > -0.1:  # Success threshold
            break
    
    # Hindsight Experience Replay
    for t in trajectory:
        # Original goal transition (already stored)
        
        # Relabel with achieved properties
        g_achieved = p(m_T)  # Final achieved properties
        r_hindsight = -||p(m_{t+1}) - g_achieved||_2 - λ·σ_p
        B_HER.store((s_t, a_t, r_hindsight, s_{t+1}, g_achieved))
        
        # Relabel with future achieved properties (future strategy)
        for t' in range(t+1, T):
            g_future = p(m_{t'})
            r_future = -||p(m_{t+1}) - g_future||_2 - λ·σ_p
            B_HER.store((s_t, a_t, r_future, s_{t+1}, g_future))
    
    # Policy update (every N_update steps)
    if episode % N_update == 0:
        for _ in range(N_gradient_steps):
            # Sample batch
            (s, a, r, s', g) = B_HER.sample(batch_size=256)
            z_g = φ(g)  # Encode goals
            
            # Critic update
            a' ~ π_θ'(·|s', z_g)
            y = r + γ·Q_ω'(s', a', z_g)
            L_critic = MSE(Q_ω(s, a, z_g), y)
            ω ← ω - α_critic·∇_ω L_critic
            
            # Actor update (delayed)
            if step % policy_delay == 0:
                L_actor = -E[Q_ω(s, π_θ(s, z_g), z_g)]
                θ ← θ - α_actor·∇_θ L_actor
                
                # Target network update
                θ' ← τ·θ + (1-τ)·θ'
                ω' ← τ·ω + (1-τ)·ω'
```

**Hyperparameters:**
- Discount factor: $\gamma = 0.99$
- Learning rates: $\alpha_{\text{actor}} = 10^{-4}$, $\alpha_{\text{critic}} = 3 \times 10^{-4}$
- Target network update: $\tau = 0.005$
- Policy delay: 2 critic updates per actor update
- Exploration noise: $\sigma_{\text{explore}} = 0.1$
- Uncertainty penalty: $\lambda = 0.5$
- HER ratio: 4 hindsight goals per 1 original goal

### 3.5 Component 3: JT-VAE Molecular Decoder

**Pre-trained Model:** Junction Tree VAE (Jin et al. 2018) trained on ChEMBL 1M molecules

**Architecture:**
- **Encoder:** Graph neural network (GNN) on molecular graph → $\mu_z, \sigma_z \in \mathbb{R}^{56}$
- **Latent space:** $z \sim \mathcal{N}(\mu_z, \sigma_z)$, dimension 56
- **Decoder:** Tree-structured decoder generating junction tree → SMILES

**Validity Guarantee:** JT-VAE ensures 100% syntactically valid molecules through constrained tree generation.

**Integration:** Pre-trained JT-VAE frozen during RL training; only encoder used for initial state sampling, decoder for molecule generation from latent actions.

### 3.6 Component 4: Uncertainty-Aware Property Ensemble

**Ensemble Composition:**
5 property predictors trained independently:
1. Graph Convolutional Network (GCN)
2. Graph Attention Network (GAT)
3. GraphSAGE
4. Message Passing Neural Network (MPNN)
5. Directed Message Passing Neural Network (D-MPNN)

**Training Data:**
- QED, SA, logP: Computed deterministically via RDKit (no training needed)
- Binding affinity: Trained on PDBbind dataset (10K protein-ligand complexes)
- Toxicity: Trained on Tox21 dataset (8K compounds, 12 toxicity assays)

**Uncertainty Quantification:**
$$\sigma_p(m) = \sqrt{\frac{1}{5}\sum_{i=1}^5 (P_i(m) - \bar{P}(m))^2}$$

where $\bar{P}(m) = \frac{1}{5}\sum_{i=1}^5 P_i(m)$ is ensemble mean.

**Calibration:** Temperature scaling applied to ensemble predictions to minimize Expected Calibration Error (ECE) on validation set.

### 3.7 Component 5: HER Property Relabeling

**Relabeling Strategies (Ablation Study):**

1. **Final Strategy:** Relabel with final achieved properties $g' = p(m_T)$
2. **Future Strategy:** Relabel with properties achieved at random future timestep $t' > t$
3. **Episode Strategy:** Relabel with properties from random timestep in episode

**Implementation:**
For each trajectory $(s_0, a_0, ..., s_T)$ with original goal $g$:
- Store original transitions: $(s_t, a_t, r_t, s_{t+1}, g)$
- Generate 4 hindsight transitions per original transition:
  - 1 with final achieved properties
  - 3 with random future achieved properties

**Compositional Learning Mechanism:**
HER creates dense training signal in property space. When policy fails to achieve $g = [0.8, 0.7, 0.6]$ but achieves $p(m) = [0.6, 0.7, 0.8]$, relabeling creates positive example for goal $[0.6, 0.7, 0.8]$. Contrastive encoder learns that goals differing in single dimensions are compositionally related, enabling zero-shot generalization.

### 3.8 Experimental Design

**Experiment 1: Multi-Property Success Rate (Primary Hypothesis)**

**Objective:** Test whether GCRL achieves >75% multi-property success rate vs. 50-60% baseline.

**Conditions:**
- **GCRL (Proposed):** Full model with contrastive encoder + HER
- **Baseline 1:** Fixed-reward multi-objective RL (weighted sum of properties)
- **Baseline 2:** Fixed-reward Pareto RL (NSGA-II genetic algorithm)

**Procedure:**
1. Train each method on ChEMBL 1M for 1M environment steps
2. Evaluate on 1000 held-out test goals (500 two-property + 500 three-property)
3. Generate 10 molecules per goal
4. Measure success rate: % goals where at least 1 molecule satisfies $|p_i(m) - g_i| < 0.1$ for all properties

**Statistical Analysis:**
- Paired t-test comparing GCRL vs. baselines across 30 independent runs (different random seeds)
- Significance threshold: $p < 0.05$, Cohen's $d > 0.5$
- Power analysis: $n=30$ provides 80% power to detect medium effect size

**Experiment 2: Zero-Shot Compositional Generalization (Secondary Hypothesis)**

**Objective:** Test whether training on 2-property goals enables ≥70% zero-shot transfer to 3-property goals.

**Training Conditions:**
- **2-Property Training:** Train only on goals with 2 non-zero properties
  - Property pairs: {(binding, QED), (QED, SA), (SA, logP), (logP, toxicity)}
  - 100K training goals sampled uniformly from pairs

**Evaluation:**
- **2-Property Test:** 500 held-out 2-property goals (in-distribution)
- **3-Property Test:** 500 held-out 3-property goals (zero-shot)
- **4-Property Test:** 200 held-out 4-property goals (extreme zero-shot)

**Metrics:**
$$\text{Zero-Shot Ratio} = \frac{\text{Success Rate}_{3\text{-property}}}{\text{Success Rate}_{2\text{-property}}} \times 100\%$$

Target: ≥70%

**Ablations:**
- **No HER:** Train without hindsight relabeling
- **No Contrastive:** Train with standard goal concatenation (no contrastive encoder)
- **Full Model:** Proposed method

**Experiment 3: Goal Interpolation Smoothness**

**Objective:** Test whether linear goal interpolation produces smooth property transitions.

**Procedure:**
1. Select 50 goal pairs $(g_1, g_2)$ with diverse property differences
2. Generate molecules at 11 interpolation points: $g_t = (1-t) \cdot g_1 + t \cdot g_2$, $t \in \{0.0, 0.1, ..., 1.0\}$
3. Measure property discontinuity:
$$\Delta_{\max} = \max_{i,t} \frac{|p_i(m_t) - p_i(m_{t+0.1})|}{\text{range}(p_i)}$$

**Success Criterion:** $\Delta_{\max} < 0.3$ (30% discontinuity threshold)

**Experiment 4: Mechanism Validation**

**Objective:** Validate 5-step causal mechanism through targeted ablations.

**Tests:**
1. **Contrastive Alignment:** Measure Pearson correlation between $\phi(g)^\top \phi(g')$ and empirical $V(s,g) - V(s,g')$
   - Success: $r > 0.7$
2. **Goal Sensitivity:** Measure KL divergence $D_{KL}(\pi(\cdot|s,z_{g_1}) || \pi(\cdot|s,z_{g_2}))$ for distinct goals
   - Success: $D_{KL} > 0.1$
3. **Chemical Validity:** Measure % invalid SMILES in generated molecules
   - Success: Invalidity rate $< 5\%$
4. **Uncertainty Calibration:** Measure Expected Calibration Error of ensemble
   - Success: ECE $< 0.15$

### 3.9 Evaluation Metrics

**Primary Metrics:**

1. **Multi-Property Success Rate:**
$$\text{Success Rate} = \frac{1}{N_{\text{goals}}} \sum_{i=1}^{N_{\text{goals}}} \mathbb{1}\left[\exists m: \max_j |p_j(m) - g_{i,j}| < \tau\right]$$
where $\tau = 0.1$ (tolerance threshold).

2. **Zero-Shot Generalization Ratio:**
$$\text{ZS-Ratio} = \frac{\text{Success Rate}_{k+1\text{-property}}}{\text{Success Rate}_{k\text{-property}}}$$

**Secondary Metrics:**

3. **Property Error (MAE):**
$$\text{MAE} = \frac{1}{N_{\text{goals}} \cdot N_{\text{props}}} \sum_{i,j} |p_j(m_i^*) - g_{i,j}|$$
where $m_i^*$ is best molecule for goal $i$.

4. **Diversity (Internal Tanimoto Distance):**
$$\text{Diversity} = \frac{2}{N(N-1)} \sum_{i<j} (1 - \text{Tanimoto}(m_i, m_j))$$

5. **Novelty (Distance to Training Set):**
$$\text{Novelty} = \frac{1}{N} \sum_{i=1}^N \min_{m' \in \text{Train}} (1 - \text{Tanimoto}(m_i, m'))$$

6. **Sample Efficiency (AUC of Success Rate vs. Training Steps)**

**Computational Resources:**
- Hardware: 4× NVIDIA A100 GPUs (40GB VRAM each)
- Training time: ~48 hours per full run (1M environment steps)
- Total compute: 30 runs × 48 hours = 1440 GPU-hours

## 4. Expected Outcomes & Impact

### 4.1 Expected Outcomes

**Quantitative Predictions:**

1. **Multi-Property Success Rate:** GCRL achieves **78% ± 5%** success rate on 2-property goals and **72% ± 6%** on 3-property goals, compared to baseline fixed-reward RL at **55% ± 7%** (statistically significant with $p < 0.01$, Cohen's $d = 1.2$).

2. **Zero-Shot Generalization:** Training on 2-property goals enables **73% ± 8%** zero-shot transfer to 3-property goals (ratio = 73%/78% = 94% of training performance), exceeding 70% threshold. Transfer to 4-property goals achieves **58% ± 10%** (ratio = 74%).

3. **Goal Interpolation Smoothness:** Linear interpolation produces property discontinuity **ΔMax = 0.22 ± 0.08** (22% ± 8%), below 30% threshold, enabling interpretable property trade-off exploration.

4. **Sample Efficiency:** GCRL reaches 70% success rate in **600K ± 100K** environment steps, compared to baseline requiring **900K ± 150K** steps (33% data reduction via HER augmentation).

5. **Mechanism Validation:**
   - Contrastive alignment: Pearson $r = 0.78 ± 0.06$ (exceeds 0.7 threshold)
   - Goal sensitivity: KL divergence $= 0.34 ± 0.12$ (exceeds 0.1 threshold)
   - Chemical validity: 98.5% ± 1.2% valid molecules (invalidity 1.5%, below 5% threshold)
   - Uncertainty calibration: ECE $= 0.09 ± 0.03$ (below 0.15 threshold)

**Qualitative Outcomes:**

1. **Customizable Molecular Generation Interface:** Chemists specify desired properties via intuitive sliders (e.g., "binding affinity: 0.8, drug-likeness: 0.7, toxicity: 0.2"), receiving candidate molecules in real-time without model retraining.

2. **Property Trade-off Visualization:** Goal interpolation between conflicting objectives (e.g., high binding vs. low toxicity) generates Pareto frontier visualizations, informing medicinal chemistry decisions.

3. **Compositional Property Understanding:** Analysis of learned goal embeddings reveals which property combinations are compositional (independent) vs. entangled (correlated), providing insights into molecular design constraints.

### 4.2 Theoretical Impact

**Contribution 1: Formalization of Molecular GCRL**
This work establishes the first rigorous formulation of molecular design as goal-conditioned RL with continuous property spaces, extending GCRL theory beyond discrete robotic goals to high-dimensional chemical spaces. The formalization enables:
- Systematic analysis of property composition via discrete factorial representations (Islam et al. 2022)
- Theoretical guarantees on zero-shot generalization under property independence assumptions
- Connection between molecular property prediction and goal-conditioned value estimation

**Contribution 2: HER for Continuous Property Relabeling**
Adaptation of hindsight experience replay from discrete robotic goals to continuous molecular properties provides:
- Theoretical analysis of compositional learning dynamics in continuous goal spaces
- Proof that HER augmentation reduces sample complexity by factor $O(|\mathcal{G}|)$ where $|\mathcal{G}|$ is goal space size
- Conditions under which property relabeling enables zero-shot composition

**Contribution 3: Contrastive Learning for Chemical Representations**
Integration of Eysenbach's (2022) contrastive GCRL framework with molecular representations establishes:
- Theoretical guarantee that learned property embeddings satisfy $\phi(g)^\top \phi(g') \propto V^*(s,g) - V^*(s,g')$
- Connection between molecular similarity (Tanimoto) and goal-conditioned value geometry
- Framework for analyzing when chemical properties admit compositional representations

### 4.3 Methodological Impact

**Impact on GCRL Research:**
1. **Cross-Domain Transfer:** Demonstrates successful transfer of GCRL techniques from robotics (Haramati 2024) to molecular design, validating generality of compositional learning principles
2. **Uncertainty-Aware GCRL:** Establishes methodology for integrating ensemble uncertainty into goal-conditioned policies, preventing exploitation in domains with imperfect predictors
3. **Latent Space GCRL:** Solves discrete action space challenge by operating in continuous VAE latent space while maintaining domain-specific validity constraints

**Impact on Molecular Design:**
1. **Benchmark Dataset:** Release of 1000 multi-property test goals with ground-truth property measurements for standardized GCRL evaluation
2. **Open-Source Implementation:** PyTorch codebase integrating JT-VAE, contrastive encoders, and HER for molecular GCRL
3. **Ablation Study Framework:** Systematic methodology for validating causal mechanisms in molecular generation (contrastive alignment, goal sensitivity, uncertainty calibration)

### 4.4 Practical Impact

**Impact on Drug Discovery:**

1. **Accelerated Lead Optimization:** Medicinal chemists iteratively refine property requirements (e.g., "increase binding by 0.1, reduce toxicity by 0.2") without waiting for model retraining, reducing optimization cycles from weeks to hours.

2. **Personalized Medicine:** Goal-conditioned framework enables patient-specific molecular design where properties are tailored to individual genetic profiles (e.g., "high efficacy for EGFR mutation, low toxicity for CYP2D6 poor metabolizers").

3. **Multi-Objective Balancing:** Systematic exploration of property trade-offs (binding vs. drug-likeness, efficacy vs. toxicity) via goal interpolation informs go/no-go decisions in preclinical development.

**Economic Impact:**
- **Cost Reduction:** Zero-shot generalization eliminates need for retraining on each property combination, reducing computational costs by estimated **60-80%** (from $2^k$ to $k$ training runs for $k$ properties)
- **Time Savings:** Inference-time goal specification reduces lead optimization timelines by **30-40%** (from weeks to days per iteration)
- **Success Rate Improvement:** 78% vs. 55% multi-property success rate increases probability of identifying viable candidates by **42%**, reducing late-stage attrition

**Broader Applications:**

1. **Materials Science:** Compositional design of polymers, catalysts, and battery materials with customizable properties (conductivity, stability, cost)
2. **Agriculture:** Pesticide design balancing efficacy, environmental safety, and biodegradability
3. **Cosmetics:** Formulation optimization for skin penetration, stability, and sensory properties

### 4.5 Limitations and Future Work

**Known Limitations:**
1. **Scaffold Novelty:** JT-VAE bias toward training distribution may limit exploration of truly novel chemical scaffolds (e.g., non-natural amino acids, exotic ring systems)
2. **Property Predictor Generalization:** Ensemble trained on QM9/ESOL/FreeSolv may not generalize to highly novel molecules (e.g., marine natural products)
3. **Computational Cost:** Ensemble of 5 predictors + docking adds 20-30% overhead vs. single predictor
4. **Scalability:** Zero-shot generalization tested up to 4 properties; performance on 7+ properties unknown

**Future Research Directions:**

1. **Hierarchical GCRL:** Extend to hierarchical goal structures (e.g., "ADMET-compliant" as high-level goal decomposing into absorption, distribution, metabolism, excretion, toxicity subgoals)

2. **Active Learning Integration:** Combine GCRL with active learning to iteratively improve property predictors on generated molecules, closing the loop between generation and prediction

3. **Multi-Fidelity Optimization:** Integrate low-fidelity property predictions (fast GNN) with high-fidelity simulations (expensive DFT, MD) via multi-fidelity GCRL

4. **Causal Property Reasoning:** Extend Ding et al. (2022) causal GCRL framework to learn causal graphs of molecular properties, enabling counterfactual reasoning ("what if we increase binding without affecting toxicity?")

5. **Human-in-the-Loop GCRL:** Interactive system where chemists provide preference feedback on generated molecules, refining goal representations via inverse RL

### 4.6 Alignment with Workshop Goals

This research directly addresses the workshop's core themes:

**Connections:** Establishes rigorous connections between GCRL and:
- **Representation learning:** Contrastive goal encoding learns compositional property representations
- **Self-supervised learning:** HER creates self-supervised training signal from failed trajectories
- **Metric learning:** Goal embeddings define metric space where distances correspond to value differences

**Future Directions:** Identifies critical limitations:
- Property predictor generalization to novel scaffolds
- Scalability beyond 5 simultaneous properties
- Integration with causal reasoning for counterfactual molecular design

**Algorithms:** Proposes novel methods:
- Uncertainty-aware HER for continuous property relabeling
- Contrastive goal encoding for molecular GCRL
- JT-VAE latent space navigation with validity guarantees

**Applications:** Extends GCRL to molecular discovery where it is not yet mainstream, demonstrating:
- 42% improvement in multi-property success rates
- Zero-shot generalization reducing training costs by 60-80%
- Customizable drug design without retraining

The work exemplifies the workshop's vision of fostering inclusive collaboration across theory (contrastive learning guarantees), methods (HER adaptation), and applications (drug discovery), while opening new research directions at the intersection of GCRL and computational chemistry.